Literature DB >> 18180979

Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG).

Yasser El Miedany1, Sally Youssef, Annie Mehanna, Naglaa Shebrya, Sherif Abu Gamra, Maha El Gaafary.   

Abstract

The Bath Ankylosing Spondylitis Functional Index (BASFI), disease activity index (BASDAI), and Global assessment (BASG) are the most commonly used instruments to assess patients suffering from ankylosing spondylitis (AS). The aim of this study was to translate, adapt, and validate these instruments into the Arabic language. Seventy-three AS patients were included in this study. One question in the BASFI questionnaire was changed to suit the Arabic culture. Also, the VAS in the questionnaires was transformed to numerical rating scales from 0 to 10. After modification, translation, and retranslation of the questionnaires, it was administered and tested for internal consistency, reliability, and construct validity. Magnetic resonance imaging (MRI) of the spine and sacroiliac joints was carried out for 69 patients; scores for disease activity and chronicity were also assessed. The adapted and translated questionnaires demonstrated acceptable comprehensibility scores with a mean of 9.3. Intraclass correlation coefficients for reliability and internal consistency was 0.973 for BASG, whereas standardized alpha ranged between 0.807 and 0.976. The modified item 9 in the BASFI demonstrated a good correlate to the principal component (0.883). When validated, all three questionnaires showed a significant correlation with enthesitis, BAS-radiology index, MRI imaging scores for activity and chronicity, C-reactive protein (CRP), and morning stiffness duration. The Arabic version of the BASFI, BASDAI, and BASG, showed adequate reliability and validity in patients with AS. The measurement properties were comparable to versions in other languages indicating that the questionnaires can be used for evaluation of AS Arabic-speaking patients.

Entities:  

Mesh:

Year:  2008        PMID: 18180979     DOI: 10.1007/s10067-007-0755-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  28 in total

1.  Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity.

Authors:  A Calin; J P Nakache; A Gueguen; H Zeidler; H Mielants; M Dougados
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.

Authors:  A Spoorenberg; D van der Heijde; E de Klerk; M Dougados; K de Vlam; H Mielants; H van der Tempel; S van der Linden
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

3.  The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity.

Authors:  H Cronstedt; A Waldner; C H Stenström
Journal:  Scand J Rheumatol Suppl       Date:  1999

4.  The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

Authors:  S D Jones; A Steiner; S L Garrett; A Calin
Journal:  Br J Rheumatol       Date:  1996-01

Review 5.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

6.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

7.  Intra-observer reliability of commonly used outcome measures in rheumatoid arthritis.

Authors:  B Hernández-Cruz; M H Cardiel
Journal:  Clin Exp Rheumatol       Date:  1998 Jul-Aug       Impact factor: 4.473

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.

Authors:  K MacKay; C Mack; S Brophy; A Calin
Journal:  Arthritis Rheum       Date:  1998-12

10.  Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires.

Authors:  Astrid Van Tubergen; Iris Debats; Liliane Ryser; John Londoño; Ruben Burgos-Vargas; Mario H Cardiel; Robert Landewé; Gerold Stucki; Désirée Van Der Heijde
Journal:  Arthritis Rheum       Date:  2002-06-15
View more
  10 in total

1.  Translation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI) for use in Ukraine.

Authors:  Oleg Nadashkevich; Oleksiy Masyk
Journal:  Clin Rheumatol       Date:  2011-04-15       Impact factor: 2.980

2.  Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis.

Authors:  Samira Rostom; Karima Benbouaaza; Bouchra Amine; Rachid Bahiri; Yousra Ibn Yacoub; Sanae Ali Ou Alla; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-04-10       Impact factor: 2.980

3.  Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.

Authors:  Katayoon Bidad; Sasan Fallahi; Mahdi Mahmoudi; Ahmadreza Jamshidi; Elham Farhadi; Alipasha Meysamie; Mohammad Hossein Nicknam
Journal:  Rheumatol Int       Date:  2011-11-20       Impact factor: 2.631

4.  Translation, cultural adaptation, and validation of the Bath questionnaires and HAQ-S in Hindi for Indian patients with ankylosing spondylitis.

Authors:  Varun Dhir; Sujay Kulkarni; Ashish Adgaonkar; Poornima Dhobe; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2012-07-25       Impact factor: 2.980

5.  Portuguese version of the bath indexes for ankylosing spondylitis patients: a cross-cultural adaptation and validation.

Authors:  F M Pimentel-Santos; T Pinto; H Santos; A Barcelos; I Cunha; J C Branco; P L Ferreira
Journal:  Clin Rheumatol       Date:  2011-10-05       Impact factor: 2.980

6.  Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients.

Authors:  Ole R Madsen; Anne Rytter; Lonnie B Hansen; Charlotte Suetta; Charlotte Egsmose
Journal:  Clin Rheumatol       Date:  2010-03-21       Impact factor: 2.980

7.  Normative values for the Bath Ankylosing Spondylitis Functional Index in the general population compared with ankylosing spondylitis patients in Morocco.

Authors:  Ghizlane Wariaghli; Fadoua Allali; Kenza Berrada; Zineb Idrissi; Ihsane Hmamouchi; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  BMC Musculoskelet Disord       Date:  2012-03-21       Impact factor: 2.362

8.  Axial Spondyloarthritis and Cigarette Smoking.

Authors:  Irène Kona Kaut; Fatima Ezzhara Abourazzak; Essouri Jamila; Florine Awassi Sènami; Desiré Diketa; Harzy Taoufik
Journal:  Open Rheumatol J       Date:  2017-05-31

9.  Gait and Axial Spondyloarthritis: Comparative Gait Analysis Study Using Foot-Worn Inertial Sensors.

Authors:  Julie Soulard; Jacques Vaillant; Athan Baillet; Philippe Gaudin; Nicolas Vuillerme
Journal:  JMIR Mhealth Uhealth       Date:  2021-11-09       Impact factor: 4.773

10.  Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients.

Authors:  Zhiming Lin; Jieruo Gu; Peigen He; Jiesheng Gao; Xiaoxia Zuo; Zhizhong Ye; Fengmin Shao; Feng Zhan; Jinying Lin; Li Li; Yanlin Wei; Manlong Xu; Zetao Liao; Qu Lin
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.